These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1835583)

  • 1. The economic evaluation of cancer treatments and programmes.
    Goddard M; Drummond M
    Eur J Cancer; 1991; 27(10):1191-6. PubMed ID: 1835583
    [No Abstract]   [Full Text] [Related]  

  • 2. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation alongside cancer trials: methodological and practical aspects.
    Bonsel GJ; Rutten FF; Uyl-de Groot CA
    Eur J Cancer; 1993; 29A Suppl 7():S10-4. PubMed ID: 8312059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome measurement in economic evaluations of growth factors.
    Jönsson B; Karlsson G
    Eur J Cancer; 1993; 29A Suppl 7():S19-22. PubMed ID: 7508726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three questions about costs and cancer clinical trials.
    Chirikos TN
    Cancer Control; 2003; 10(1):71-8. PubMed ID: 12598857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methodology of economic assessment: example in oncology].
    Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
    Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop.
    Neymark N; Kiebert W; Torfs K; Davies L; Fayers P; Hillner B; Gelber R; Guyatt G; Kind P; Machin D; Nord E; Osoba D; Revicki D; Schulman K; Simpson K
    Eur J Cancer; 1998 Aug; 34(9):1317-33. PubMed ID: 9849412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's cost-effective in cancer care?
    Cancer Discov; 2011 Nov; 1(6):OF1-2. PubMed ID: 22586658
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic analyses in clinical trials for cooperative groups: operational considerations.
    Bennett CL; Waters TM
    Cancer Invest; 1997; 15(5):448-53. PubMed ID: 9316627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research.
    Fitzpatrick R; Davies L
    Br J Cancer; 1998 May; 77(10):1543-8. PubMed ID: 9635826
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient costs on clinical trials.
    Presant CA
    J Natl Cancer Inst; 2000 Sep; 92(17):1441-3. PubMed ID: 10974083
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
    Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs studies show clinical trials, standard therapy may be equal.
    Reynolds T
    J Natl Cancer Inst; 2000 Jul; 92(14):1116-8. PubMed ID: 10904079
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of Cancer Value Frameworks for Patients, Payers, and Physicians.
    Chandra A; Shafrin J; Dhawan R
    JAMA; 2016 May; 315(19):2069-70. PubMed ID: 27187295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quality of life in oncological studies].
    Flechtner H
    Onkologie; 2001 Sep; 24 Suppl 5():22-7. PubMed ID: 11600809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information by the German Cancer Society].
    Drings P
    Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):M164-6. PubMed ID: 9036060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Economic evaluation of targeted cancer therapy].
    Ikeda S
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):967-70. PubMed ID: 23986036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of quality-adjusted life years (QALYs) in the economic appraisal of health care.
    Kawachi I; Bethwaite P; Bethwaite J
    N Z Med J; 1990 Feb; 103(883):46-8. PubMed ID: 2106105
    [No Abstract]   [Full Text] [Related]  

  • 19. When is treatment for cancer economically justified? Discussion paper.
    Jennett B; Buxton M
    J R Soc Med; 1990 Jan; 83(1):25-8. PubMed ID: 2106031
    [No Abstract]   [Full Text] [Related]  

  • 20. The economic impact of therapy on cancer patients.
    Murphy GP; Prestifilippo J; Antman K; Berkman BJ; Huber SL; Kaufman D; Knox WA; Lawrence W; Levine RJ; Young FE
    Cancer; 1993 Nov; 72(9 Suppl):2862-4. PubMed ID: 8402521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.